We found that the acquisition of strong PH3 resistance necessitates the avoidance of OXPHOS via the introduction of a few non-synonymous mutations in mitochondrial genes encoding ND as well as nuclear genes encoding DLD, concomitant with metabolic reprogramming, a recognized hallmark of cancer metabolism. The gene discussed is DLD; the disease is cancer.